|
US4115577A
(en)
*
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4183936A
(en)
*
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4013652A
(en)
*
|
1972-06-19 |
1977-03-22 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzoxazine
|
|
US4219550A
(en)
*
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
|
US4997831A
(en)
*
|
1988-09-01 |
1991-03-05 |
Glaxo Group Limited |
Lactam derivatives
|
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
|
EP0380155A1
(en)
*
|
1989-01-19 |
1990-08-01 |
Duphar International Research B.V |
8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
HK1043112A1
(zh)
|
1999-06-15 |
2002-09-06 |
Bristol-Myers Squibb Pharma Company |
取代的稠杂环γ-咔啉
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
HUP0303432A3
(en)
*
|
2000-12-20 |
2012-09-28 |
Bristol Myers Squibb Co |
Substituted pyridoindoles as serotonin agonists and antagonists and pharmaceutical compositions containing the compounds and their use
|
|
JP4346307B2
(ja)
|
2000-12-20 |
2009-10-21 |
ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー |
セロトニン受容体アゴニストおよびアンタゴニストとしての置換されたピラジノキノキサリン誘導体
|
|
IL156261A0
(en)
|
2000-12-20 |
2004-01-04 |
Bristol Myers Squibb Co |
Pyrroloquinoline and pyridoquinoline derivatives and pharmaceutical compositions containing the same
|
|
US6849619B2
(en)
*
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
EP1429776A2
(en)
*
|
2001-09-21 |
2004-06-23 |
PHARMACIA & UPJOHN COMPANY |
Tricyclic indole derivatives as 5-ht ligands
|
|
ES2364046T3
(es)
*
|
2002-12-19 |
2011-08-23 |
Bristol-Myers Squibb Company |
Gamma-carbolinas tricíclicas sustituidas utilizadas como agonistas y antagonistas de los receptores de la serotonina.
|
|
KR101805914B1
(ko)
|
2007-03-12 |
2017-12-06 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
|
US8575186B2
(en)
|
2009-10-05 |
2013-11-05 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
|
|
AU2012207335A1
(en)
|
2011-01-19 |
2013-07-25 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
|
AU2013245702A1
(en)
|
2012-04-14 |
2014-11-13 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2014145192A1
(en)
|
2013-03-15 |
2014-09-18 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2015085004A1
(en)
*
|
2013-12-03 |
2015-06-11 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
KR20170012210A
(ko)
|
2014-04-04 |
2017-02-02 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
CA2944755A1
(en)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
PL3838274T3
(pl)
|
2016-01-26 |
2024-04-02 |
Intra-Cellular Therapies, Inc. |
Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
|
|
DK3407889T3
(da)
|
2016-03-25 |
2021-08-09 |
Intra Cellular Therapies Inc |
Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet
|
|
US11014925B2
(en)
|
2016-03-28 |
2021-05-25 |
Intra-Cellular Therapies, Inc. |
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
|
|
JP2019513143A
(ja)
|
2016-03-28 |
2019-05-23 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規塩類および結晶
|
|
US10682354B2
(en)
|
2016-03-28 |
2020-06-16 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
|
WO2018126143A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2018126140A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2018175969A1
(en)
|
2017-03-24 |
2018-09-27 |
Intra-Cellular Therapies, Inc. |
Novel compositions and methods
|
|
CA3071137A1
(en)
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
Prodrugs of substituted heterocycle fused gamma-carbolines
|
|
CN111093665A
(zh)
|
2017-07-26 |
2020-05-01 |
细胞内治疗公司 |
有机化合物
|
|
WO2019183341A1
(en)
|
2018-03-23 |
2019-09-26 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
MX2020013116A
(es)
|
2018-06-06 |
2021-05-12 |
Intra Cellular Therapies Inc |
Sales y cristales novedosos.
|
|
WO2019237037A1
(en)
|
2018-06-08 |
2019-12-12 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
JP7483671B2
(ja)
|
2018-06-11 |
2024-05-15 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
置換ヘテロ環縮合ガンマ-カルボリン類合成
|
|
US12144808B2
(en)
|
2018-08-29 |
2024-11-19 |
Intra-Cellular Therapies, Inc. |
Compositions and methods
|
|
AU2019331490B2
(en)
|
2018-08-31 |
2025-04-24 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
JP7546546B2
(ja)
|
2018-08-31 |
2024-09-06 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
新規方法
|
|
EP4134101A1
(en)
|
2019-07-07 |
2023-02-15 |
Intra-Cellular Therapies, Inc. |
Deuterated lumateperone for the treatment of the bipolar ii disorder
|
|
US12414948B2
(en)
|
2022-05-18 |
2025-09-16 |
Intra-Cellular Therapies, Inc. |
Methods
|